Research programme : skin disorder therapeutics - Evommune
Latest Information Update: 09 Dec 2020
At a glance
- Originator Evommune
- Class Skin disorder therapies; Small molecules
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- Research Skin disorders